RTW INVESTMENTS, LP's Net Worth

$1.65 Billion

Estimate Recalculated Feb 16, 2024 05:08PM EST

Who is RTW INVESTMENTS, LP?

RTW INVESTMENTS, LP has an estimated net worth of $1.65 Billion. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., Milestone Pharmaceuticals Inc., Tarsus Pharmaceuticals, Inc., Stoke Therapeutics, Inc., Athira Pharma, Inc., DermTech, Inc., ROCKET PHARMACEUTICALS, INC., Avidity Biosciences, Inc., Renovacor, Inc., Landos Biopharma, Inc., TELA Bio, Inc., and Orchestra BioMed Holdings, Inc..

SEC CIK

RTW INVESTMENTS, LP's CIK is 0001493215

Past Insider Trading and Trends

2021 was RTW INVESTMENTS, LP's most active year for acquiring shares with 32 total transactions. RTW INVESTMENTS, LP's most active month to acquire stocks was the month of November. 2021 was RTW INVESTMENTS, LP's most active year for disposing of shares, totalling 7 transactions. RTW INVESTMENTS, LP's most active month to dispose stocks was the month of July. 2023 saw RTW INVESTMENTS, LP paying a total of $68,960,010.45 for 6,939,088 shares, this is the most they've acquired in one year. In 2021 RTW INVESTMENTS, LP cashed out on 30,842,423 shares for a total of $42,814,523.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prometheus Biosciences, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.26M
$19.00
3.26M
Mar 16
Form 3
0
0
No matching records found

Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.54%
-1.06M
3.26M
Mar 22
Form 4
0
$8.71
8.63M
Sep 7
Form 4
0
0
May 21
Form 4
0
0
Oct 27
Form 4
0
0
Jul 22
Form 4
+0.20%
8.57K
$10.71
$91,832.63
4.32M
Mar 18 - Mar 19
Form 4
+1.85%
78.26K
$18.95
$1,483,083.85
4.31M
Mar 2
Form 4
+6.82%
270K
$16.25
$4,387,500.00
4.23M
Jan 13
Form 4
+0.58%
22.77K
$15.50
$352,978.22
3.96M
Dec 30 - Dec 31
Form 4
+11.31%
400K
$16.00
$6,400,000.00
3.94M
Nov 20
Form 4
+0.16%
5.49K
$17.40
$95,454.83
3.54M
Oct 10 - Oct 15
Form 4
+0.23%
8.15K
$17.79
$144,978.84
3.53M
Oct 1 - Oct 3
Form 4
3.52M
$15.00
3.52M
May 9
Form 3
0
0
No matching records found

Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $29.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.27%
-450.00K
$29.98
-$13,491,000.00
2.01M
May 7
Form 3
0
0
No matching records found

Stoke Therapeutics, Inc. (STOK) Snapshot price: $4.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.46%
-16.43K
$28.70
-$471,631.15
3.54M
Nov 8
Form 4
+3.03%
104.87K
$29.24
$3,066,843.09
3.56M
Nov 4
Form 4
+2.03%
68.78K
$28.59
$1,966,612.94
3.46M
Oct 30 - Nov 1
Form 4
+0.94%
31.56K
$21.96
$693,029.20
3.39M
Oct 1
Form 4
3.36M
$18.00
3.36M
Jun 19
Form 3
0
0
No matching records found

Athira Pharma, Inc. (ATHA) Snapshot price: $3.075

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+595.42%
2.29M
$17.00
2.67M
Sep 18
Form 3
0
0
No matching records found